In this retrospective, single institution cohort study, we saw a low rate of distant metastases for asymptomatic low-risk EBC patients (T1/2, N0) with occurrence of metastatic disease being 0% for Ki-67 < 25% and 1.1% for Ki-67 ≥ 25%. Here, MKI67 is linked to metastatic neoplasm.